Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1843 1
1875 1
1889 1
1901 1
1904 1
1905 4
1915 1
1916 1
1917 1
1918 1
1919 1
1922 1
1923 1
1925 1
1927 2
1928 2
1929 1
1931 2
1934 1
1935 1
1937 1
1938 3
1939 3
1941 2
1942 1
1943 1
1944 1
1946 7
1947 15
1948 10
1949 6
1950 12
1951 12
1952 11
1953 14
1954 16
1955 4
1956 8
1957 9
1958 8
1959 4
1960 7
1961 5
1962 3
1963 1
1964 7
1965 6
1966 7
1967 10
1968 9
1969 10
1970 9
1971 5
1972 5
1973 7
1974 7
1975 10
1976 9
1977 4
1978 8
1979 9
1980 11
1981 12
1982 10
1983 13
1984 9
1985 27
1986 14
1987 19
1988 16
1989 14
1990 13
1991 16
1992 20
1993 28
1994 18
1995 18
1996 21
1997 22
1998 15
1999 22
2000 19
2001 15
2002 14
2003 19
2004 18
2005 39
2006 30
2007 29
2008 39
2009 43
2010 56
2011 82
2012 51
2013 75
2014 89
2015 85
2016 90
2017 97
2018 120
2019 102
2020 132
2021 162
2022 148
2023 115
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

2,173 results

Results by year

Filters applied: . Clear all
Page 1
Nonlinear progression across the occult transition establishes cancer lethality.
Ginzel JD, Chapman H, Sills JE, Allen EJ, Barak LS, Cardiff RD, Borowsky AD, Lyerly HK, Rogers BW, Snyder JC. Ginzel JD, et al. Among authors: allen ej. bioRxiv [Preprint]. 2024 Apr 25:2024.04.23.590826. doi: 10.1101/2024.04.23.590826. bioRxiv. 2024. PMID: 38712192 Free PMC article. Preprint.
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.
Saliby RM, Labaki C, Jammihal TR, Xie W, Sun M, Shah V, Saad E, Kane MH, Kashima S, Sadak K, El Zarif T, Poduval D, Motzer RJ, Powles T, Rini BI, Albiges L, Pal SK, McGregor BA, McKay RR, Signoretti S, Van Allen EM, Shukla SA, Choueiri TK, Braun DA. Saliby RM, et al. Among authors: van allen em. Cancer Cell. 2024 Apr 4:S1535-6108(24)00087-4. doi: 10.1016/j.ccell.2024.03.002. Online ahead of print. Cancer Cell. 2024. PMID: 38579722
2,173 results